Esperion Therapeutics
ESPR
ESPR
182 hedge funds and large institutions have $214M invested in Esperion Therapeutics in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 50 increasing their positions, 44 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.31% less ownership
Funds ownership: 72.18% → 65.88% (-6.3%)
30% less capital invested
Capital invested by funds: $304M → $214M (-$89.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
182
Holding in Top 10
1
Calls
$3.08M
Puts
$2.19M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$3.67M | |
| 3 | +$2.55M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.76M |
| 5 |
TSC
Two Seas Capital
Rye,
New York
|
+$1.4M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$5.13M | |
| 3 | -$5.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4.63M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.29M |